Cerezyme

Active Ingredient(s): Imiglucerase
FDA Approved: * May 23, 1994
Pharm Company: * GENZYME
Category: Enzymes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Cerezyme Overview

Imiglucerase is a medication used in the treatment of Gaucher's disease.[1][2] It is a recombinant DNA-produced analogue of human β-glucocerebrosidase. Cerezyme is a freeze-dried medicine containing imiglucerase, manufactured by Genzyme Corporation. It is given intravenously after reconstitution as a treatment for Type 1 Gaucher's disease. It is available in formulations containing 200 or 400 units per vial. The specific activity of highly purified human...

Read more Cerezyme Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Imiglucerase

Recent Cerezyme Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Cerezyme: (2 results)

Sorted by National Drug Code

• 58468-1983 Cerezyme 40 U/Ml Intravenous Injection, Powder, Lyophilized, for Solution by Genzyme Corporation
• 58468-4663 Cerezyme 40 U/Ml Intravenous Injection, Powder, Lyophilized, for Solution by Genzyme Corporation

Other drugs which contain Imiglucerase or a similar ingredient: (1 result)

• IMIGLUCERASE